title: Sarcoidosis induced by tocilizumab: a paradoxical event?
authors.affiliation: Hopital Lapeyronie, Rhumatologie;
authors.forename: Anaiz
authors.initials: A
authors.lastname: Nutz
authors.forename: Charlotte
authors.initials: C
authors.lastname: Pernet
authors.forename: Bernard
authors.initials: B
authors.lastname: Combe
authors.forename: Jean-David
authors.initials: JD
authors.lastname: Cohen
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D012507:Sarcoidosis / Q000139:chemically induced*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab